Long-dreaded Amazon.com threat to drug middlemen draws close


  • TECH
  • Thursday, 01 Feb 2018

(FILES) This file photo taken on December 28, 2016 shows the logo of US electronic commerce and cloud computing company Amazon in Vertou, France. Amazon said January 18, 2018 it had narrowed to 20 its options for a second headquarters for the sprawling technology and lifestyle company headed by Jeff Bezos, the world's richest individual. After 238 cities from North America submitted bids, Amazon announced its short list included three in the vicinity of the US capital Washington, and the Canadian city of Toronto. / AFP PHOTO / LOIC VENANCE

A day that prescription-drug middlemen had long feared finally arrived. 

The industry awoke to the news Jan 30 that Amazon.com Inc was joining with Berkshire Hathaway Inc and JPMorgan Chase & Co to form a new health-care business, in an attempt by three of the world’s best-known companies to contain the spiralling cost of keeping their US workers healthy. 

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Apple’s new AirTag tracker is better, but not upgrade-worthy
Waymo raises US$16bil (RM62.8bil) in robotaxi race with Tesla
What is Slippery Fish? A secret project to win Olympic speedskating medals with help from an app
Nintendo posts quarterly profit rise, sees no major hit from chip price spike
Some companies tie AI to layoffs, but the reality is more complicated
JPJ: MyDigital ID as sole log-in for app now postponed to March 1
Musk Inc? Billionaire combines his rocket and AI businesses before an expected IPO this year
OpenClaw's AI agent does everything, even social media
Exclusive-SpaceX, xAI set share exchange ratio at 0.1433, source says
Chinese tech giants trade cash for AI buzz

Others Also Read